Ekso Bionics (Nasdaq:EKSO) announced today that it received FDA 510(k) clearance for its EksoNR robotic exoskeleton. Richmond, California–based Ekso Bionics designed the EksoNR technology for use with Multiple Sclerosis (MS) patients. According to a news release, EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use in patients with MS, significantly expanding […]
Prosthetics
Myomo slides as Q4 earnings miss despite massive sales beat
Myomo (NYSE:MYO) shares were down this morning on fourth-quarter results that were mixed compared to the consensus forecast. The Boston-based medical robotics company posted losses of $2.7 million, or 52¢ per share, on sales of $4 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on sales […]
What happens when bionic eye implants suddenly go dark?
An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Myomo touts independent study of its MyoPro myoelectric orthosis
Myomo (NYSE:MYO) announced today that new research demonstrated benefits with its MyoPro myolectric orthosis for the upper limbs. Results from the study, funded by the U.S. Army Medical Research Acquisition Activity, and supported by the Office of Secretary of Defense for Health Affairs, were published in the peer-reviewed journal Frontiers in Neurology. Data showed “statistically significant improvements” […]
Össur launches next-gen Power Knee
Össur (NSDQ:OSSR) announced today that it launched its new Power Knee microprocessor prosthetic knee system. Reykjavik, Iceland–based Össur designed the motor-powered “smart” prosthesis with advanced algorithms for detecting human movement patterns, learning and adjusting to the wearer’s speed and cadence in real-time. The platform creates motion through active powered assistance while distinguishing what surface, incline or […]
Myomo skyrockets after hours on Street-beating Q3
Myomo (NYSE:MYO) shares got a big boost after hours today on third-quarter results that came in ahead of the consensus forecast. MYO shares were up 10.9% at $11.52 per share after hours. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.9%. The Boston-based […]
Coloplast to buy Atos Medical for more than $2B
Coloplast will spend 16 billion DKK kr. (roughly $2.4 billion) to acquire laryngectomy care device company Atos Medical. The Danish medtech giant in a Monday news release said Atos Medical’s goal of making life easier for people living with a neck stoma closely aligns with Coloplast’s purpose to serve people with intimate healthcare needs. Paris-based […]
Cleveland Clinic reports bionic arm breakthrough
Cleveland Clinic researchers say they’ve developed a bionic system that takes a big step toward restoring natural arm function for patients with upper limb amputations. Upper-limb amputees often have to constantly watch their prosthetics while using them to make corrections in how much grasping force they use, but Cleveland Clinic said patients testing the new […]
Myomo rises after hours on more than 200% revenue increase
Myomo (NYSE:MYO) shares ticked up after hours today on third-quarter results that topped the consensus forecast. MYO shares were up 15.9% at $5.60 per share after hours. The Cambridge, Mass.-based company posted losses of -$2.8 million, or -70¢ per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a slight […]
Myomo names chief medical officer
Myomo (NYSE:MYO) today said it appointed Dr. Harry Kovelman as chief medical officer, effective immediately. Kovelman will be responsible for overseeing the company’s patient advocacy organization. He will work with commercial and government payer organizations to increase patient access to the MyoPro product line. “I’m pleased to welcome Dr. Kovelman to Myomo as we continue to […]
Myomo lands Medicare coverage
Myomo (NYSE:MYO) announced that it received authorization to be a Medicare provider through the Centers for Medicare & Medicaid Services. CMS, under the U.S. Dept. of Health and Human Services, now includes Cambridge, Mass.-based Myomo in its Medicare Supplier Directory at Medicare.gov, which enables Myomo to bill Medicare directly when it delivers its MyoPro orthosis in […]
